secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001628280-25-022664
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo receives Nasdaq deficiency notice for bid price below $1.00; 180 days to cure
--------------------------------------------------------------------------------

- On April 30, 2025, Nasdaq notified Sangamo that its stock closed below $1.00 for 30 consecutive business days.
- Company has until October 27, 2025 to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant, may qualify for a second 180-day period if other listing standards are met.
- Failure to cure could result in delisting from the Nasdaq Capital Market.
- Sangamo will monitor bid price and evaluate options including a reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000162828025022664/0001628280-25-022664-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000162828025022664/sgmo-20250430.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-022664

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer